CN · Field Sheet
FIELD SHEET — GREEN TEA MFI-GREENT-20261017-FS
Survey index / GREEN TEA

Green tea.

Camellia sinensis
Green tea leaf infusion; catechin, caffeine and cardiometabolic literature.
SEALED MFI-GREENT-20261017-FS · RELEASED 2026-10-17
SHEET FINGERPRINTMFI-GREENT-20261017-FS
707INCLUDED
2,296EXCLUDED
27DUPLICATE
243NON-TRANSFERABLE
1OUT OF CUTOFF
Survey totalsScroll ↓
3,274records surveyed
707studies
40claims graded
250observations
12,078graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-b1541b39c1c6f59eGRADE VERY_LOW
green tea constituents — inflammation
direction BENEFIT · dose 250 mg/kg · duration 1 year; 2 weeks; 28 day; 30 days; 4 days; 4 weeks
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
25bound studies
Bound studies (4 shown of 25)
STU-11528ee17703ead0
UNSPECIFIED · HUMAN · 2023 · RoB NOT_ASSESSABLE
6 endpoints
STU-3ad3a851774786dd
IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-4be28102aef75195
UNSPECIFIED · HUMAN · 2024 · RoB NOT_ASSESSABLE
6 endpoints
STU-4dec156f00ed9703
UNSPECIFIED · HUMAN · 2026 · RoB NOT_ASSESSABLE
3 endpoints
Quantitative observations
dose 250 mg/kg · validated
n 6 · validated
duration 28 day · failed extraction
Opposition screen
SCREEN · 55 candidates considered · 3 bound as opposing
SYNTHESIS SYN-64dba6d38b4400 — outcome QUALITATIVE_ONLY · BENEFIT ×25 · not_assessed_quantitatively · 25 members
PROVENANCE → epmc:PPR673345, epmc:40157268, epmc:39459643 · PKG 8841a0c1e8bacb21…
CLAIM · CLM-5c56e70b49422778GRADE VERY_LOW
green tea constituents — antioxidant
direction BENEFIT · dose 250 mg/kg; 50 mg/kg · duration 12 weeks; 2 weeks; 28 days; 30 days; 90 days
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
24bound studies
Bound studies (4 shown of 24)
STU-11528ee17703ead0
UNSPECIFIED · HUMAN · 2023 · RoB NOT_ASSESSABLE
6 endpoints
STU-3a01cc8030bd558c
IN_VITRO · IN_VITRO · 2025 · 90 days · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-3ad3a851774786dd
IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-488cd01906cddb52
ANIMAL · ANIMAL · 2026 · 30 days · RoB SOME_CONCERNS
2 endpoints
Quantitative observations
dose 250 mg/kg · validated
n 6 · validated
effect p < 0.01 · failed extraction
Opposition screen
SCREEN · 60 candidates considered · 3 bound as opposing
SYNTHESIS SYN-485827e1be5556 — outcome QUALITATIVE_ONLY · BENEFIT ×24 · not_assessed_quantitatively · 24 members
PROVENANCE → epmc:PPR673345, epmc:40822523, epmc:40157268 · PKG 8841a0c1e8bacb21…
Bounded preview — representative records only. The full release ships 40 claims and 250 observations.